Renaissance BioScience: Edison Open House Healthcare 2022

Renaissance BioScience: Edison Open House Healthcare 2022

Private: Renaissance BioScience — 1 video in collection

More on this equity

Renaissance BioScience is an Environmental Impact company whose bioengineering platform technologies develop innovative, market-ready, functional microorganisms that provide solutions to a broad range of health and environmental problems.

• Tell us about the company’s technology platform and the applications it is currently being used for.
• What is driving demand for alternatives to chemical pesticides?
• How do RNA-based pesticides work and what advantages do they have over conventional ones?
• Does this remove concerns about residue and pest resistance?
• What is special about Renaissance BioScience’s production and delivery mechanisms?
• How does this affect acrylamide in toast?
• Is your recent funding from the National Research Council of Canada Industrial Research Assistance Program sufficient to take your technology for use in biocontrol applications through to commercialisation?
• Which key events should investors look out for over the next 12 months?


You may also be interested in these:

Healthcare

Mendus – executive interview

Healthcare

Oryzon Genomics – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free